Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Garzotto

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
BJU International|January 22, 2009
Lower urinary tract symptoms increase the risk of falls in older menJ Kellogg Parsons, Jolee Mougey, Lori Lambert, et al.
Cancer|September 1, 2005
Recursive partitioning for risk stratification in men undergoing repeat prostate biopsiesMark Garzotto, Yon Park, Solange Mongoue-Tchokote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15Chung-Ying Huang, Tomasz M Beer, Celestia S Higano, et al.
BJU International|September 11, 2008
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancerJoseph S Chan, Tomasz M Beer, David I Quinn, et al.
Urologic Oncology|July 13, 2019
The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomyNicholas H Chakiryan, Ann Martinez Acevedo, Michael J Conlin, et al.
Urology|May 25, 2010
Acupuncture for hot flashes in patients with prostate cancerTomasz M Beer, Maria Benavides, Sandra L Emmons, et al.
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Cancer|February 10, 2010
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancerMark Garzotto, Celestia S Higano, Catherine O'Brien, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
BJU International|January 22, 2009
Lower urinary tract symptoms increase the risk of falls in older menJ Kellogg Parsons, Jolee Mougey, Lori Lambert, et al.
Cancer|September 1, 2005
Recursive partitioning for risk stratification in men undergoing repeat prostate biopsiesMark Garzotto, Yon Park, Solange Mongoue-Tchokote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15Chung-Ying Huang, Tomasz M Beer, Celestia S Higano, et al.
BJU International|September 11, 2008
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancerJoseph S Chan, Tomasz M Beer, David I Quinn, et al.
Urologic Oncology|July 13, 2019
The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomyNicholas H Chakiryan, Ann Martinez Acevedo, Michael J Conlin, et al.
Urology|May 25, 2010
Acupuncture for hot flashes in patients with prostate cancerTomasz M Beer, Maria Benavides, Sandra L Emmons, et al.
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Cancer|February 10, 2010
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancerMark Garzotto, Celestia S Higano, Catherine O'Brien, et al.
Pageof 8